The Karen Van Rassel Leadership Award was created through a generous grant from Celgene following Karen’s retirement, to honour her commitment to Lymphoma Coalition and tremendous achievements in the global blood cancer community during her tenure as the organisation’s CEO.
The Karen Van Rassel Leadership Award will be granted to a Lymphoma Coalition Member Organisation that best demonstrates the following criteria:
Exemplary Improvement in the Care of People Living with Lymphoma
- Demonstrates a positive and tangible impact on the care of people living with lymphoma. This may include but is not limited to:
- Policy change to improve the care of people living with lymphoma.
- System change in hospitals, clinics or other institutions that improves the care of people living with lymphoma.
- Education and support for people living with lymphoma, based on credible information.
Outstanding Global Leadership
- Demonstrates a leadership role in Lymphoma Coalition activities and drives organisational goals forward (globally or locally).
- Works collaboratively and creatively within LC activities including World Lymphoma Awareness Day, Global Summit, etc.
- Contributes to regional or global blood cancer or oncology communities in meaningful ways.
A Commitment to Organisational Sustainability
- Commits to their organisation’s sustainability by identifying and working towards long- and short-term strategic goals that include financial viability and engaging an effective, dedicated team of staff (as applicable) and volunteers.
2020 Award Recipient
Lymphoma Coalition is pleased to present the 2020 Karen Van Rassel Leadership Award to the Lymphoma Patient Association/Udruženje Obolelih Od Limfoma (LIPA) in Serbia.
Innovation, integrity, and responsibility are in the heart of LIPA’s work and their collaborative mindset focuses on contributing to better care of patients and their family members. LIPA’s ambition is to be the most collaborative and trusted patient organization in Serbia and broader, with a strategy built sourcing for shared value, innovating responsibly, and acting for patients. LIPA had an extraordinary year and was able to drive real change for people affected by lymphoma in Serbia, despite the impact of the COVID-19 pandemic. This was all done by a small team of very dedicated volunteers.
LIPA has long had a robust offering of educational and support sessions in place for those affected by lymphomas, including CLL. This year they added:
- A patient helper programme where well-trained volunteers are placed in larger hospitals to help bridge the interaction between patients and healthcare providers. These volunteers ensure patients get the information and support they need while being respectful of doctor’s time. Before the pandemic forced the program to halt, they had helped over 100 patients.
- A bi-monthly workshops for older patients, which unfortunately had to stop due to COVID-19. Recognising this group is vulnerable and may be more impacted by isolation, a weekly online session has replaced these face-to-face meetings for the time being.
Digital tools became more important for us all when COVID-19 changed how healthcare is delivered.
- This year LIPA launched the Linfom App that provides credible resources for educational purposes and allows patients to track their symptoms and overall experience in a format that can be shared with their care team. There are already over 1,000 people using the app.
- With the advent of the pandemic, patients were concerned how to get professional help when needed so LIPA, in cooperation with IT experts, created a specially designed platform for online consultation for people with lymphoma and CLL. The platform offers patients access to lymphoma/CLL experts (7 doctors), a nutritionist and a psychologist through online video consultation. Approximately 50 patients each month are using this service.
- They also do an annual digital campaign through social media that shares tools and resources to help patients cope with everyday life.
- They have developed a platform on their website for the new Share for the Future project, which provides information about AI in medicine, Big Data, personalized medicine and the importance of sharing data.
While Serbia guarantees universal healthcare coverage through compulsory health insurance, in reality, there are numerous obstacles in providing healthcare services. In conjunction with the Serbian Hematology Association, LIPA met with government officials and were able to have a special access scheme for novel therapies introduced into the country, allowing more patients access to much needed newer treatments. This is a remarkable end result and an excellent example of how different members of the lymphoma community working together can bring about much needed change.
This is only a sampling of LIPA’s efforts. It clearly shows that a small group of committed people can have a large impact, even in challenging circumstances.
About Karen Van Rassel
Karen Van Rassel is the retired Chief Executive Officer of Lymphoma Coalition.
Karen was a founding member of Lymphoma Coalition and held the position of CEO from 2010 till 2018, during which time she took a special interest in Lymphoma Coalition’s growth and membership support. Prior to that, Karen was the Executive Director of Lymphoma Canada.
Before her work in the lymphoma community, Karen was involved in a number of children’s charities in various roles, holding a board position as well as working as Director of Corporate and Business Development.
She brought 20 years’ experience from the Marketing and Advertising industry to these charities.
Karen is now a proud grandmother and busy with volunteer work.